Location:Room Munich, North Hall (Level 1)
This session will evaluate, interactively discuss and critique recent submitted evidence about prostate cancer biopsy techniques and protocols. An emphasis will be placed on innovative techniques an approaches to increase procedural safety and diagnostic accuracy, and patient experience.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Institutes: 1Istituto Clinico Humanitas, Irccs, Dept. of Urology, Milan, Italy, 2Università Degli Studi Di Perugia, Dept. of Medicine, Perugia, Italy, 3Humanitas Mater Domini, Dept. of Urology, Varese, Italy, 4Istituto Clinico Humanitas, Irccs, Humanitas University, Dept. of Urology, Milan, Italy
Institutes: 1University of Turin, Dept. of Surgical Sciences, Urology, Turin, Italy, 2University of Turin, Dept. of Surgical Sciences, Radiology Unit, Turin, Italy, 3University of Turin, Dept. of Surgical Sciences, Turin, Italy, 4University of Turin, Dept. of Medical Sciences, Pathology Unit, Turin, Italy
Institutes: Brigham and Women’s Hospital, Harvard Medical School, Dept. of Urology, Boston, United States of America
Institutes: 1Imperial Healthcare NHS Trust, Dept. of Urology, London, United Kingdom, 2Ziocom Group, , Singapore, Singapore, 3Singapore General Hosital, Dept. of Urology, Singapore, Singapore, 4University Hospital Tübingen, Dept. of Urology, Tübingen, Germany, 5Monash University, Dept. of Urology, Melbourne, Australia